Enfermedad de Alzheimer
Noticias de actualidad, información científica, recursos para pacientes y cuidadores, atención especializada, eventos y otras novedades
Buscar
jueves, 18 de mayo de 2017
jueves, 11 de mayo de 2017
viernes, 28 de abril de 2017
domingo, 7 de agosto de 2016
sábado, 6 de agosto de 2016
Physical activity recommendations to protect against temporal lobe atrophy in older adults at risk for AD
An article published in the last edition of Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring presents the results of a study oriented to compare temporal lobe volumes between older adults who met PAR and those who did not.
Acoording with the authors, Individuals at-risk for AD experience accelerated rates of brain atrophy. These results suggest that regular engagement in PA at or above PAR could attenuate this decline.
Tanshinonas y Enfermedad Mental: De la química la medicina
The prevalence of mental diseases, especially neurodegenerative disorders, is ever-increasing, while treatment options for such disorders are limited and insufficient. In this scarcity of available medication, it is a feasible strategy to search for potential drugs among natural compounds, such as those found in plants. One such plant source is the root of Chinese sage, Salvia miltiorrhiza Bunge (Labiatae), which contains several compounds reported to possess neuroprotective activities.
The most important of these compounds are tanshinones, which have been reported to possess ameliorative activity against a myriad of mental diseases such as Alzheimer's disease, cerebral ischemia/reperfusion injury, and glioma, along with promoting neuronal differentiation and manifesting antinociceptive and anticonvulsant outcomes. This review offers a critical evaluation of the utility of tanshinones to treat mental illnesses, and sheds light on the underlying mechanisms through which these naturally occurring compounds confer neuroprotection.
Reference. Reviews in the Neurosciences 2016
viernes, 29 de julio de 2016
Diferencias metacognitivas entre Enfermedad de Alzheimer y Demencia Fronto Temporal: Claves del diagnóstico diferencial
En la edición de agosto de la revista American Journal of Alzheimer's Disease and Other Dementias se publicó una revisión sistemática acerca de las diferencias en las mediciones metacognitivas entre pacientes con demencia frontotemporal (DFT) y enfermedad de Alzheimer (EA), en la que se concluyó que es un parámetro de gran utilidad para alcanzar el diagnóstico diferencial entre estos dos cuadros.
Suscribirse a:
Entradas (Atom)